Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Idrx
Growth Score
59
CB Rank
17701
Heat Score
20
Save
Actions
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
Acquired by
GlaxoSmithKline
Founded
obfuscated
obfuscation
Private
Series B
Cambridge
,
Massachusetts
,
United States
11-50
www.idrx.com/
Biotechnology
Life Science
Oncology
Product Research
Idrx
Section: Technology
Actions